Researchers from Virginia Commonwealth University suggest a discussion of colorectal cancer screening options could confuse patients and prevent them from undergoing screening, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
The researched studied 6,100 patients ages 50-75. A questionnaire was mailed in 2007 asking which colorectal cancer screening options they discussed with their respective physicians. Analyses were restricted to respondents who discussed one or more screening options.
Results showed that patients who discussed two or more colorectal screening options were 1.6 times more likely to be confused than those who discussed just one option, and patients who reported being confused were 1.8 times more likely to not undergo screening than those who were not confused.
Read the abstract about screening options and adherence.
Read other coverage about colorectal cancer screening:
- IU Gastroenterologist Says Colonoscopy Can Be a Viable Tool for CRC Prevention
- New Test Measuring DNA Methylation Levels Could Help Detect CRC
- Four out of Five Providers Fail to Follow All CRC Screening Guidelines
The researched studied 6,100 patients ages 50-75. A questionnaire was mailed in 2007 asking which colorectal cancer screening options they discussed with their respective physicians. Analyses were restricted to respondents who discussed one or more screening options.
Results showed that patients who discussed two or more colorectal screening options were 1.6 times more likely to be confused than those who discussed just one option, and patients who reported being confused were 1.8 times more likely to not undergo screening than those who were not confused.
Read the abstract about screening options and adherence.
Read other coverage about colorectal cancer screening:
- IU Gastroenterologist Says Colonoscopy Can Be a Viable Tool for CRC Prevention
- New Test Measuring DNA Methylation Levels Could Help Detect CRC
- Four out of Five Providers Fail to Follow All CRC Screening Guidelines